29 October 2013 - Deborah Wilkes
Archived
Legislation may need to be changed if the European Union's centralised procedure is to become an attractive route to market for non-prescription medicines, according to Dr Mark Griffiths, head of regulatory EMEA at Pfizer Consumer Healthcare.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.